Longitudinal Description and Prediction of Smoking Among Borderline Patients: An 18-Year Follow-Up Study

Overview

Journal J Clin Psychiatry

Specialty Psychiatry

Date 2023 Nov 9

PMID 37943989

Authors

Marcelo J A A Branas

Frances R Frankenburg

Christina M Temes

Garrett M Fitzmaurice

Mary C Zanarini

Affiliations

Soon will be listed here.

Abstract

The objectives of this study were (1) to compare smoking between recovered and non-recovered patients with borderline personality disorder (BPD) over the course of 18 years and (2) to assess baseline predictors of tobacco use in patients with BPD. A total of 264 borderline patients were interviewed concerning their smoking history beginning at the 6-year follow-up wave in a longitudinal study of the course of BPD (McLean Study of Adult Development) and re-interviewed at 2-year intervals over the next 18 years. Initial data collection of the larger study happened between June 1992 and December 1995, and the and the Revised Diagnostic Interview for Borderlines (DIB-R) were used as the diagnostic instruments for BPD. Recovered patients had a 48% lower prevalence of smoking than non-recovered patients at 6-year follow-up (a significant difference; = .01). Also, the rate of decline in smoking for the recovered group was 68% and was significantly faster ( = .008) than for the non-recovered group over the subsequent 18 years. Alcohol abuse or dependence (relative risk [RR] = 1.22; 95% CI, 1.06-1.40; = .005), lower levels of education (RR = 1.28; 95% CI, 1.15-1.42; < .001), and higher levels of the defense mechanism of denial (RR = 1.08; 95% CI, 1.03-1.13; = .002) were significant predictors of smoking in borderline patients in multivariate analyses. Taken together, the results of this study suggest that recovery status was an important element in the prevalence of smoking among borderline patients over time. They also suggest that smoking was predicted by 3 factors: prior psychopathology, demographics, and psychological maturity.

References

Zanarini M, Conkey L, Temes C, Fitzmaurice G . Randomized Controlled Trial of Web-Based Psychoeducation for Women With Borderline Personality Disorder. J Clin Psychiatry. 2017; 79(3). PMC: 5764827. DOI: 10.4088/JCP.16m11153. View

Zanarini M, Frankenburg F, DeLuca C, Hennen J, Khera G, Gunderson J . The pain of being borderline: dysphoric states specific to borderline personality disorder. Harv Rev Psychiatry. 1999; 6(4):201-7. DOI: 10.3109/10673229809000330. View

Leichsenring F, Heim N, Leweke F, Spitzer C, Steinert C, Kernberg O . Borderline Personality Disorder: A Review. JAMA. 2023; 329(8):670-679. DOI: 10.1001/jama.2023.0589. View

Jamal A, King B, Neff L, Whitmill J, Babb S, Graffunder C . Current Cigarette Smoking Among Adults - United States, 2005-2015. MMWR Morb Mortal Wkly Rep. 2016; 65(44):1205-1211. DOI: 10.15585/mmwr.mm6544a2. View

Frankenburg F, Zanarini M . The association between borderline personality disorder and chronic medical illnesses, poor health-related lifestyle choices, and costly forms of health care utilization. J Clin Psychiatry. 2005; 65(12):1660-5. DOI: 10.4088/jcp.v65n1211. View

Braveman P, Gottlieb L . The social determinants of health: it's time to consider the causes of the causes. Public Health Rep. 2014; 129 Suppl 2:19-31. PMC: 3863696. DOI: 10.1177/00333549141291S206. View

Spitzer R, Williams J, GIBBON M, First M . The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry. 1992; 49(8):624-9. DOI: 10.1001/archpsyc.1992.01820080032005. View

Schlaepfer I, Hoft N, Ehringer M . The genetic components of alcohol and nicotine co-addiction: from genes to behavior. Curr Drug Abuse Rev. 2009; 1(2):124-34. PMC: 2600802. DOI: 10.2174/1874473710801020124. View

Donald S, Chartrand H, Bolton J . The relationship between nicotine cessation and mental disorders in a nationally representative sample. J Psychiatr Res. 2013; 47(11):1673-9. DOI: 10.1016/j.jpsychires.2013.05.011. View

10.

Grant B, Chou S, Saha T, Pickering R, Kerridge B, Ruan W . Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013: Results From the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry. 2017; 74(9):911-923. PMC: 5710229. DOI: 10.1001/jamapsychiatry.2017.2161. View

11.

Frankenburg F, Zanarini M . Relationship between cumulative BMI and symptomatic, psychosocial, and medical outcomes in patients with borderline personality disorder. J Pers Disord. 2011; 25(4):421-31. PMC: 3203730. DOI: 10.1521/pedi.2011.25.4.421. View

12.

Hopkins D, Razi S, Leeks K, Priya Kalra G, Chattopadhyay S, Soler R . Smokefree policies to reduce tobacco use. A systematic review. Am J Prev Med. 2010; 38(2 Suppl):S275-89. DOI: 10.1016/j.amepre.2009.10.029. View

13.

Zanarini M, Frankenburg F . Attainment and maintenance of reliability of axis I and II disorders over the course of a longitudinal study. Compr Psychiatry. 2001; 42(5):369-74. DOI: 10.1053/comp.2001.24556. View

14.

Peretti-Watel P, Constance J, Guilbert P, Gautier A, Beck F, Moatti J . Smoking too few cigarettes to be at risk? Smokers' perceptions of risk and risk denial, a French survey. Tob Control. 2007; 16(5):351-6. PMC: 2598568. DOI: 10.1136/tc.2007.020362. View

15.

Zanarini M, Frankenburg F, Reich D, Fitzmaurice G . Time to attainment of recovery from borderline personality disorder and stability of recovery: A 10-year prospective follow-up study. Am J Psychiatry. 2010; 167(6):663-7. PMC: 3203735. DOI: 10.1176/appi.ajp.2009.09081130. View

16.

Sansone R, Sansone L . Substance use disorders and borderline personality: common bedfellows. Innov Clin Neurosci. 2011; 8(9):10-3. PMC: 3196330. View

17.

Plante D, Frankenburg F, Fitzmaurice G, Zanarini M . Relationship between maladaptive cognitions about sleep and recovery in patients with borderline personality disorder. Psychiatry Res. 2013; 210(3):975-9. PMC: 3840073. DOI: 10.1016/j.psychres.2013.08.004. View

18.

Smith P, Mazure C, McKee S . Smoking and mental illness in the U.S. population. Tob Control. 2014; 23(e2):e147-53. PMC: 4201650. DOI: 10.1136/tobaccocontrol-2013-051466. View

19.

Jemal A, Thun M, Ward E, Henley S, Cokkinides V, Murray T . Mortality from leading causes by education and race in the United States, 2001. Am J Prev Med. 2007; 34(1):1-8. DOI: 10.1016/j.amepre.2007.09.017. View

20.

Tomko R, Trull T, Wood P, Sher K . Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning. J Pers Disord. 2014; 28(5):734-50. PMC: 3864176. DOI: 10.1521/pedi_2012_26_093. View